| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,385.4 | 1,291.3 |
| Gross profit | 526.7 | 469.7 |
| Profit before tax | 196.5 | 189.4 |
| Net income | 151.7 | 145.8 |
| EPS (diluted, $ a share) | $0.89 | $0.83 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +4.0% |
|---|---|
| Revenue, year on year | +7.3% |
| Gross margin | 38.0% |
| Operating margin | 15.2% |
10-Q filed with the SEC, NYSE: G. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Genpact LTD: key numbers
- Share price
- $44.28Close, Nov 16
- Market cap
- $7.4B
- Shares outstanding
- 167.23MLatest SEC cover page
- Sector
- Trade & Services
- Industry
- Services-Management Consulting ServicesSIC 8742
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Genpact LTD
All →Genpact SVP and CHRO Piyush Mehta Sells $8.61M of Stock
Piyush Mehta, SVP and CHRO, sold 200,000 shares of Genpact LTD at $43.05 a share, worth $8.61M in total on Nov 10, 2026. Shares held after the trade: 156,823 (-56.1%).
- Value
- $8.61M
- Shares
- 200,000
- Price
- $43.05
- Role
- SVP and CHRO
- Holding change
- -56.1%
- Trade date
- Nov 10, 2026
Genpact Shareholder Meeting
Genpact Limited held a special general meeting of shareholders on November 10, 2026, where shareholders approved a proposal to change the company's jurisdiction of incorporation from Bermuda to the State of Delaware. The domestication involves discontinuing as a Bermuda exempted company and continuing as a Delaware corporation.
Genpact Insider Carol Lindstrom Sells $101K of Stock
Carol Lindstrom sold 2,364 shares of Genpact LTD at $42.56 a share, worth $101K in total on Nov 9, 2026. Shares held after the trade: 25,342 (-8.5%).
- Value
- $101K
- Shares
- 2,364
- Price
- $42.56
- Holding change
- -8.5%
- Trade date
- Nov 9, 2026
Genpact Financial Results
Genpact reported Q3 2026 financial results with total revenue growing 7.3% year-over-year to $1.385 billion, driven by 30.3% growth in its Advanced Technology Solutions segment. The company raised its full-year 2026 guidance for gross margin and adjusted diluted EPS following strong execution in its pivot to 'Agentic Operations'.
- Term
- Q3 2026
“Q3 was another clear proof point that our pivot to Agentic Operations is working, as our flywheel continues to accelerate. Total revenue grew 7.3% year-over-year, and Advanced Technology Solutions revenue growth increased to 30.3%.”
Balkrishan “BK” Kalra, President and CEO, Genpact
“Our Q3 results reflect the strength of our differentiation and execution, with strong revenue growth, significant year-over-year gross margin expansion, and adjusted diluted EPS growth of 10.3%, and we are raising our full year 2026 gross margin and adjusted diluted EPS guidance to reflect this.”
Sumita Pandit, Chief Financial Officer, Genpact
Genpact Executive Compensation
Genpact Limited entered into a separation agreement with former CFO Michael Weiner, who stepped down effective September 8, 2026. The agreement includes a $683,500 severance payment, a $45,327 healthcare coverage payment, a $168,534 prorated 2027 bonus, and accelerated vesting for certain equity awards.
- Counterparty
- Michael Weiner
- Term
- 12 months
Genpact President and CEO Balkrishan Kalra Sells $368K of Stock
Balkrishan Kalra, President and CEO, sold 10,000 shares of Genpact LTD at $36.79 a share, worth $368K in total on Sep 14, 2026. Shares held after the trade: 501,114 (-2.0%).
- Value
- $368K
- Shares
- 10,000
- Price
- $36.79
- Role
- President and CEO
- Holding change
- -2.0%
- Trade date
- Sep 14, 2026